Semler Scientific Inc. (SMLR)

NASDAQ: SMLR · IEX Real-Time Price · USD
43.00
+0.80 (1.90%)
At close: Aug 10, 2022 4:00 PM
42.20
-0.80 (-1.86%)
After-hours: Aug 10, 2022 7:23 PM EDT

Company Description

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States.

The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups.

The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.

Semler Scientific Inc.
Country United States
Founded 2007
IPO Date Feb 21, 2014
Industry Health Care Equipment & Supplies
Sector Health Care
Employees 124
CEO Douglas Murphy-Chutorian

Contact Details

Address:
911 Bern Ct Ste 110
San Jose, California 95112-1242
United States
Phone 877-774-4211
Website semlerscientific.com

Stock Details

Ticker Symbol SMLR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 0001554859
CUSIP Number 81684M104
ISIN Number US81684M1045
Employer ID 26-1367393
SIC Code 3845

Key Executives

Name Position
Dr. Douglas Murphy-Chutorian M.D. Chief Executive Officer, Corporate Secretary and Director
Andrew B. Weinstein Senior Vice President of Finance and Accounting
Dr. Herbert J. Semler Founder and Chairman Emeritus
Robert G. McRae Chief Technical Officer
Dennis Rosenberg Chief Marketing Officer

Latest SEC Filings

Date Type Title
Jul 5, 2022 4 Statement of changes in beneficial ownership of securities
May 6, 2022 10-Q Quarterly report [Sections 13 or 15(d)]
May 2, 2022 8-K Current report
Apr 18, 2022 4 Statement of changes in beneficial ownership of securities
Mar 17, 2022 8-K Current report
Mar 7, 2022 S-8 Securities to be offered to employees in employee benefit plans
Mar 4, 2022 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 1, 2022 4 Statement of changes in beneficial ownership of securities
Feb 28, 2022 8-K Current report
Feb 24, 2022 4 Statement of changes in beneficial ownership of securities